Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Viktor Brabec

Showing results (201-210 of 242) with videos related to

Pageof 25
Sort By:
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|May 12, 2015
Inhibition of DNA topoisomerases I and II and growth inhibition of HL-60 cells by novel acridine-based compoundsJana Janočková, Jana Plšíková, Jana Kašpárková, et al.
ACS Chemical Biology|April 8, 2017
New Acridine Thiourea Gold(I) Anticancer Agents: Targeting the Nucleus and Inhibiting Vasculogenic MimicrySergio A Pérez, Concepción de Haro, Consuelo Vicente, et al.
Journal of Medicinal Chemistry|December 23, 2023
Novel 2-(5-Arylthiophen-2-yl)-benzoazole Cyclometalated Iridium(III) dppz Complexes Exhibit Selective Phototoxicity in Cancer Cells by Lysosomal Damage and OncosisJana Kasparkova, Alba Hernández-García, Hana Kostrhunova, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 6, 2003
Induced-fit recognition of DNA by organometallic complexes with dynamic stereogenic centersHaimei Chen, John A Parkinson, Olga Nováková, et al.
Cancer Research|March 3, 2007
High-throughput screening identifies novel agents eliciting hypersensitivity in Fanconi pathway-deficient cancer cellsEike Gallmeier, Tomas Hucl, Jonathan R Brody, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|January 26, 2016
Emergence of the First Catalytic Oligonucleotides in a Formamide-Based Origin ScenarioJudit E Šponer, Jiří Šponer, Olga Nováková, et al.
Inorganic Chemistry|June 22, 2021
Hetero-Bis-Conjugation of Bioactive Molecules to Half-Sandwich Ruthenium(II) and Iridium(III) Complexes Provides Synergic Effects in Cancer Cell CytotoxicityLorenzo Biancalana, Hana Kostrhunova, Lucinda K Batchelor, et al.
Journal of Medicinal Chemistry|April 30, 2019
A Subset of New Platinum Antitumor Agents Kills Cells by a Multimodal Mechanism of Action Also Involving Changes in the Organization of the Microtubule CytoskeletonHana Kostrhunova, Juraj Zajac, Vojtech Novohradsky, et al.
Dalton Transactions (Cambridge, England : 2003)|October 3, 2019
Copper(ii) complexes with tridentate Schiff base-like ligands: solid state and solution structures and anticancer activityKatja Dankhoff, Madeleine Gold, Luisa Kober, et al.
Molecular Pharmaceutics|August 3, 2011
Replacement of a thiourea with an amidine group in a monofunctional platinum-acridine antitumor agent. Effect on DNA interactions, DNA adduct recognition and repairHana Kostrhunova, Jaroslav Malina, Amanda J Pickard, et al.
Pageof 25

Showing results (201-210 of 242) with videos related to

Sort By:
Pageof 25
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|May 12, 2015
Inhibition of DNA topoisomerases I and II and growth inhibition of HL-60 cells by novel acridine-based compoundsJana Janočková, Jana Plšíková, Jana Kašpárková, et al.
ACS Chemical Biology|April 8, 2017
New Acridine Thiourea Gold(I) Anticancer Agents: Targeting the Nucleus and Inhibiting Vasculogenic MimicrySergio A Pérez, Concepción de Haro, Consuelo Vicente, et al.
Journal of Medicinal Chemistry|December 23, 2023
Novel 2-(5-Arylthiophen-2-yl)-benzoazole Cyclometalated Iridium(III) dppz Complexes Exhibit Selective Phototoxicity in Cancer Cells by Lysosomal Damage and OncosisJana Kasparkova, Alba Hernández-García, Hana Kostrhunova, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 6, 2003
Induced-fit recognition of DNA by organometallic complexes with dynamic stereogenic centersHaimei Chen, John A Parkinson, Olga Nováková, et al.
Cancer Research|March 3, 2007
High-throughput screening identifies novel agents eliciting hypersensitivity in Fanconi pathway-deficient cancer cellsEike Gallmeier, Tomas Hucl, Jonathan R Brody, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|January 26, 2016
Emergence of the First Catalytic Oligonucleotides in a Formamide-Based Origin ScenarioJudit E Šponer, Jiří Šponer, Olga Nováková, et al.
Inorganic Chemistry|June 22, 2021
Hetero-Bis-Conjugation of Bioactive Molecules to Half-Sandwich Ruthenium(II) and Iridium(III) Complexes Provides Synergic Effects in Cancer Cell CytotoxicityLorenzo Biancalana, Hana Kostrhunova, Lucinda K Batchelor, et al.
Journal of Medicinal Chemistry|April 30, 2019
A Subset of New Platinum Antitumor Agents Kills Cells by a Multimodal Mechanism of Action Also Involving Changes in the Organization of the Microtubule CytoskeletonHana Kostrhunova, Juraj Zajac, Vojtech Novohradsky, et al.
Dalton Transactions (Cambridge, England : 2003)|October 3, 2019
Copper(ii) complexes with tridentate Schiff base-like ligands: solid state and solution structures and anticancer activityKatja Dankhoff, Madeleine Gold, Luisa Kober, et al.
Molecular Pharmaceutics|August 3, 2011
Replacement of a thiourea with an amidine group in a monofunctional platinum-acridine antitumor agent. Effect on DNA interactions, DNA adduct recognition and repairHana Kostrhunova, Jaroslav Malina, Amanda J Pickard, et al.
Pageof 25